Invus Public Equities, L.p. - Net Worth and Insider Trading
Invus Public Equities, L.p. Net Worth
The estimated net worth of Invus Public Equities, L.p. is at least $258 Million dollars as of 2024-04-28. Invus Public Equities, L.p. is the 10% Owner of Scholar Rock Holding Corp and owns about 11,259,438 shares of Scholar Rock Holding Corp (SRRK) stock worth over $164 Million. Invus Public Equities, L.p. is the Director, 10% Owner of Lexicon Pharmaceuticals Inc and owns about 35,402,689 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $56 Million. Invus Public Equities, L.p. is also the 10% Owner of GlycoMimetics Inc and owns about 8,589,064 shares of GlycoMimetics Inc (GLYC) stock worth over $14 Million. Besides these, Invus Public Equities, L.p. also holds Seer Inc (SEER) , Generation Bio Co (GBIO) , Omega Therapeutics Inc (OMGA) , Agenus Inc (AGEN) , SQZ Biotechnologies Co (SQZB) . Details can be seen in Invus Public Equities, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Invus Public Equities, L.p. has not made any transactions after 2023-10-12 and currently still holds the listed stock(s).
Transaction Summary of Invus Public Equities, L.p.
Invus Public Equities, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Invus Public Equities, L.p. owns 8 companies in total, including Generation Bio Co (GBIO) , Lexicon Pharmaceuticals Inc (LXRX) , and Scholar Rock Holding Corp (SRRK) among others .
Click here to see the complete history of Invus Public Equities, L.p.’s form 4 insider trades.
Insider Ownership Summary of Invus Public Equities, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GBIO | Generation Bio Co | 2020-06-16 | 10 percent owner |
LXRX | Lexicon Pharmaceuticals Inc | 2020-12-16 | director & 10 percent owner |
SRRK | Scholar Rock Holding Corp | 2023-10-12 | 10 percent owner |
AGEN | Agenus Inc | 2008-05-10 | 10 percent owner |
SQZB | SQZ Biotechnologies Co | 2020-11-03 | 10 percent owner |
SEER | Seer Inc | 2021-02-01 | 10 percent owner |
OMGA | Omega Therapeutics Inc | 2021-08-03 | 10 percent owner |
GLYC | GlycoMimetics Inc | 2023-02-24 | 10 percent owner |
Invus Public Equities, L.p. Latest Holdings Summary
Invus Public Equities, L.p. currently owns a total of 8 stocks. Among these stocks, Invus Public Equities, L.p. owns 11,259,438 shares of Scholar Rock Holding Corp (SRRK) as of October 12, 2023, with a value of $164 Million and a weighting of 63.42%. Invus Public Equities, L.p. owns 35,402,689 shares of Lexicon Pharmaceuticals Inc (LXRX) as of December 16, 2020, with a value of $56 Million and a weighting of 21.68%. Invus Public Equities, L.p. also owns 8,589,064 shares of GlycoMimetics Inc (GLYC) as of February 24, 2023, with a value of $14 Million and a weighting of 5.46%. The other 5 stocks Seer Inc (SEER) , Generation Bio Co (GBIO) , Omega Therapeutics Inc (OMGA) , Agenus Inc (AGEN) , SQZ Biotechnologies Co (SQZB) have a combined weighting of 9.44% among all his current holdings.
Latest Holdings of Invus Public Equities, L.p.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SRRK | Scholar Rock Holding Corp | 2023-10-12 | 11,259,438 | 14.53 | 163,599,634 |
LXRX | Lexicon Pharmaceuticals Inc | 2020-12-16 | 35,402,689 | 1.58 | 55,936,249 |
GLYC | GlycoMimetics Inc | 2023-02-24 | 8,589,064 | 1.64 | 14,086,065 |
SEER | Seer Inc | 2021-02-01 | 5,588,366 | 1.91 | 10,673,779 |
GBIO | Generation Bio Co | 2020-06-16 | 2,814,191 | 2.90 | 8,161,154 |
OMGA | Omega Therapeutics Inc | 2021-08-03 | 2,273,530 | 2.27 | 5,160,913 |
AGEN | Agenus Inc | 2008-05-10 | 29,444 | 11.69 | 344,200 |
SQZB | SQZ Biotechnologies Co | 2020-11-03 | 160,631 | 0.05 | 7,469 |
Holding Weightings of Invus Public Equities, L.p.
Invus Public Equities, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Invus Public Equities, L.p. has made a total of 6 transactions in Scholar Rock Holding Corp (SRRK) over the past 5 years, including 5 buys and 1 sells. The most-recent trade in Scholar Rock Holding Corp is the acquisition of 2,199,931 shares on October 12, 2023, which cost Invus Public Equities, L.p. around $15 Million.
According to the SEC Form 4 filings, Invus Public Equities, L.p. has made a total of 1 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lexicon Pharmaceuticals Inc is the acquisition of 10,937,500 shares on December 16, 2020, which cost Invus Public Equities, L.p. around $35 Million.
According to the SEC Form 4 filings, Invus Public Equities, L.p. has made a total of 4 transactions in GlycoMimetics Inc (GLYC) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in GlycoMimetics Inc is the acquisition of 100,000 shares on February 24, 2023, which cost Invus Public Equities, L.p. around $170,000.
More details on Invus Public Equities, L.p.'s insider transactions can be found in the Insider Trading History of Invus Public Equities, L.p. table.Insider Trading History of Invus Public Equities, L.p.
- 1
Invus Public Equities, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Invus Public Equities, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Invus Public Equities, L.p. is 10.88%. GuruFocus also compares Invus Public Equities, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Invus Public Equities, L.p. within 3 months outperforms 11 times out of 24 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Invus Public Equities, L.p.'s insider trading performs compared to the benchmark.
Performance of Invus Public Equities, L.p.
Average Return
-11.58%
Outperforming Transactions
36%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 7.45 | 10.88 | -12.44 | -11.58 | -53.37 | -37.44 |
Relative Return to S&P 500(%) | 5.71 | 5.21 | -17.26 | -25.96 | -59.2 | -50.62 |
Invus Public Equities, L.p. Ownership Network
Ownership Network List of Invus Public Equities, L.p.
Ownership Network Relation of Invus Public Equities, L.p.
Invus Public Equities, L.p. Owned Company Details
What does Generation Bio Co do?
Who are the key executives at Generation Bio Co?
Invus Public Equities, L.p. is the 10 percent owner of Generation Bio Co. Other key executives at Generation Bio Co include CHIEF OPERATING OFFICER Antoinette Paone , CHIEF LEGAL OFFICER Yalonda Howze , and CHIEF STRATEGY OFFICER Phillip Samayoa .
Generation Bio Co (GBIO) Insider Trades Summary
Over the past 18 months, Invus Public Equities, L.p. made no insider transaction in Generation Bio Co (GBIO). Other recent insider transactions involving Generation Bio Co (GBIO) include a net sale of 10,590 shares made by Antoinette Paone , a net purchase of 20,000 shares made by Dannielle Appelhans , and a net purchase of 342,960 shares made by Rowland Charles A Jr .
In summary, during the past 3 months, insiders sold 0 shares of Generation Bio Co (GBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 12,455 shares of Generation Bio Co (GBIO) were sold and 551,455 shares were bought by its insiders, resulting in a net purchase of 539,000 shares.
Generation Bio Co (GBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Generation Bio Co Insider Transactions
Invus Public Equities, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Invus Public Equities, L.p.. You might contact Invus Public Equities, L.p. via mailing address: C/o The Invus Group, Llc, 750 Lexington Avenue, 30th Floor, New York Ny 10022.